NCT04370834 2025-02-04Tocilizumab for Patients With Cancer and COVID-19 DiseaseNational Cancer Institute (NCI)Phase 2 Terminated1 enrolled 10 charts
NCT02002052 2019-09-25FLAIRLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sPhase 2 Terminated29 enrolled